1 year return (CAGR)
158.73%
AnaptysBio Inc Exchange (NASDAQ, USD)
ANAB
53.92
-1.00 (-1.82%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
40.36%
5 year return (CAGR)
16.26%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.60B
Price/Sales
6.87
Ent value
1.66B
Price/Book
125.24
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
12.38
EPS growth
-10.37%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 55.07 |
| Daily high | 56.03 |
| Daily low | 50.61 |
| Daily Volume | 756K |
| All-time high | 128.55 |
| 1y analyst estimate | 87.44 |
| Beta | 0.40 |
| EPS (TTM) | -0.93 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 9 Mar 2026 |
Downside potential
Loading...
Downside potential data
| ANAB | S&P500 | |
| Current price drop from All-time high | -58.06% | -0.58% |
| Highest price drop | -92.08% | -56.47% |
| Date of highest drop | 8 Nov 2019 | 9 Mar 2009 |
| Avg drop from high | -64.74% | -10.68% |
| Avg time to new high | 43 days | 12 days |
| Max time to new high | 2151 days | 1805 days |
News
